Nouvelles thérapies orales anticancéreuses: quels enjeux pour la société ?

Gildas Appéré, Thierry Cailleau (), Christophe Daniel (), Françoise Grudé and Muriel Travers ()
Additional contact information
Thierry Cailleau: UA - Université d'Angers
Christophe Daniel: UA - Université d'Angers
Françoise Grudé: UNICANCER/ICO - Institut de Cancérologie de l'Ouest [Angers/Nantes] - UNICANCER
Muriel Travers: UA - Université d'Angers

Post-Print from HAL

Date: 2012-06-08
References: Add references at CitEc
Citations:

Published in 5ème Symposium de l’Axe SHS du Cancéropôle Grand Ouest, CHU d'Angers, Jun 2012, Angers, France

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-04489040

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().